stockrow
Friday 6 November 2026
Export BHVN’s income statement to Excel — free account
Biohaven Ltd.
BHVN Healthcare Biotechnology
- EPS
- +47.8%
- Free cash flow
- +26.6%
- Total debt
- −1.48%
Quarter to September 2026, against a year earlier
14.41
0.51
+3.67%
Follow BHVN
Alert me
Biohaven Ltd. (BHVN) Book value per share
Biohaven Ltd.'s book value per share at the end of fiscal 2025 was 0.5×, down 89.6% from 4.6× in fiscal 2024. At the end of the quarter to 30 September 2026 it was −0.7×. Over the past ten years it has ranged from −10.0× (fiscal 2020) to 12.0× (fiscal 2022); the current reading is higher than 45% of that period. Biohaven Ltd. ranks 560th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 0.5× | (89.58%) |
| FY2024 | 4.6× | (22.79%) |
| FY2023 | 6.0× | (50.08%) |
| FY2022 | 12.0× | 1,266.86% |
| FY2021 | 0.9× | — |
| FY2020 | −10.0× | — |
| FY2019 | −0.2× | — |
| FY2018 | 3.9× | (18.74%) |
| FY2017 | 4.7× | — |
| FY2016 | −0.1× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | −0.7× | — |
| Jun 2026 | 0.1× | (90.76%) |
| Mar 2026 | 0.9× | 81.34% |
| Dec 2025 | 0.5× | — |
| 40 more quarters | Free account |
Against its own ten years
Low −10.0×
High 12.0×
Ten-year median
0.9×
Current reading's percentile
45
Book value per share against peers
| Company | Book value per share |
|---|---|
| PVLA Palvella Therapeutics, Inc. compare | 15.1× |
| CLDX Celldex Therapeutics, Inc. compare | 9.2× |
| VCEL Vericel Corporation compare | 7.5× |
| VERA Vera Therapeutics, Inc. compare | 5.7× |
| AUPH Aurinia Pharmaceuticals Inc compare | 4.9× |
| IMNM Immunome, Inc. compare | 4.6× |
| ADMA ADMA Biologics Inc compare | 2.0× |
| LKFT Lakefront Biotherapeutics - Sponsored ADR compare | 0.0× |
| BHVN Biohaven Ltd. | −0.7× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))